A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs may enter the market.
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.
Read twice and referred to the Committee on Finance.
Referred to the Subcommittee on Health.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line